The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALTENERGY ACQUISITION CORP | *W EXP 10/29/202 | 02157M116 | 6,894 | 186,315 | SH | SOLE | 186,315 | 0 | 0 | |||
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | 32,992,655 | 13,197,062 | SH | SOLE | 13,197,062 | 0 | 0 | |||
| CENTRAL & EASTERN EUROPE FD | COM | 153436100 | 2,973,896 | 305,015 | SH | SOLE | 305,015 | 0 | 0 | |||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 2,647,711 | 885,522 | SH | SOLE | 885,522 | 0 | 0 | |||
| ESPERION THERAPEUTICS INC NE | NOTE 4.000% 11/1 | 29664WAB1 | 2,848,125 | 4,900,000 | PRN | SOLE | 4,900,000 | 0 | 0 | |||
| GENWORTH FINL INC | COM CL A | 37247D106 | 10,135,377 | 1,517,272 | SH | SOLE | 1,517,272 | 0 | 0 | |||
| GLOBAL SHIP LEASE INC NEW | COM CL A | Y27183600 | 37,608,073 | 1,897,481 | SH | SOLE | 1,897,481 | 0 | 0 | |||
| INNOVATE CORP | COM | 45784J105 | 1,339,615 | 1,089,118 | SH | SOLE | 1,089,118 | 0 | 0 | |||
| LANVIN GROUP HOLDINGS LIMITE | *W EXP 01/14/202 | G5380J118 | 14,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| LIBERTY MEDIA CORP DEL | COM LBTY LIV S C | 531229722 | 4,265,115 | 114,071 | SH | SOLE | 114,071 | 0 | 0 | |||
| LIBERTY MEDIA CORP DEL | COM LBTY SRM S C | 531229789 | 13,131,882 | 456,285 | SH | SOLE | 456,285 | 0 | 0 | |||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 2,785,643 | 231,558 | SH | SOLE | 231,558 | 0 | 0 | |||
| MAIDEN HOLDINGS LTD | SHS | G5753U112 | 4,501,671 | 1,965,795 | SH | SOLE | 1,965,795 | 0 | 0 | |||
| NEXTNAV INC. | COMMON STOCK | 65345N106 | 11,618,536 | 2,610,907 | SH | SOLE | 2,610,907 | 0 | 0 | |||
| NEXTNAV INC. | *W EXP 10/28/202 | 65345N114 | 347,725 | 482,951 | SH | SOLE | 482,951 | 0 | 0 | |||
| ODYSSEY MARINE EXPL INC | COM NEW | 676118201 | 2,552,427 | 548,909 | SH | SOLE | 548,909 | 0 | 0 | |||
| PITNEY BOWES INC | COM | 724479100 | 1,643,400 | 373,500 | SH | SOLE | 373,500 | 0 | 0 | |||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 17,866,930 | 1,591,000 | SH | SOLE | 1,591,000 | 0 | 0 | |||
| SABRE GLBL INC | NOTE 4.000% 4/1 | 78573NAE2 | 4,869,074 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | |||
| TRINITY BIOTECH PLC | SPON ADR NEW | 896438306 | 175,683 | 409,517 | SH | SOLE | 409,517 | 0 | 0 | |||
| INNOVATE CORP | NOTE 7.500% 8/0 | 404139AG2 | 2,536,481 | 5,658,000 | PRN | SOLE | 5,658,000 | 0 | 0 | |||